Microbix End Period Cash Flow vs Depreciation Analysis
MBX Stock | CAD 0.36 0.01 2.86% |
Microbix Biosystems financial indicator trend analysis is infinitely more than just investigating Microbix Biosystems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbix Biosystems is a good investment. Please check the relationship between Microbix Biosystems End Period Cash Flow and its Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
End Period Cash Flow vs Depreciation
End Period Cash Flow vs Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbix Biosystems End Period Cash Flow account and Depreciation. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Microbix Biosystems' End Period Cash Flow and Depreciation is 0.83. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Depreciation in the same time period over historical financial statements of Microbix Biosystems, assuming nothing else is changed. The correlation between historical values of Microbix Biosystems' End Period Cash Flow and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Microbix Biosystems are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of End Period Cash Flow i.e., Microbix Biosystems' End Period Cash Flow and Depreciation go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
End Period Cash Flow
Depreciation
Depreciation indicates how much of Microbix Biosystems value has been used up. For tax purposes Microbix Biosystems can deduct the cost of the tangible assets it purchases as business expenses. However, Microbix Biosystems must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most indicators from Microbix Biosystems' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. As of the 11th of December 2024, Selling General Administrative is likely to grow to about 7.9 M, while Tax Provision is likely to drop 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 11.1M | 7.5M | 8.6M | 4.4M | Total Revenue | 19.1M | 16.5M | 19.0M | 19.9M |
Microbix Biosystems fundamental ratios Correlations
Click cells to compare fundamentals
Microbix Biosystems Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbix Biosystems fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 15.6M | 28.8M | 33.1M | 35.7M | 41.0M | 43.1M | |
Short Long Term Debt Total | 6.2M | 7.7M | 5.8M | 6.6M | 7.6M | 4.5M | |
Other Current Liab | 1.5M | 1.8M | 1.8M | 2.0M | 2.3M | 1.3M | |
Total Current Liabilities | 4.1M | 5.2M | 2.7M | 4.3M | 5.0M | 2.7M | |
Total Stockholder Equity | 6.6M | 18.6M | 24.9M | 24.6M | 28.3M | 29.7M | |
Property Plant And Equipment Net | 7.4M | 8.1M | 8.9M | 8.9M | 10.3M | 5.8M | |
Net Debt | 6.1M | (2.3M) | (7.7M) | (5.0M) | (5.7M) | (5.4M) | |
Retained Earnings | (41.9M) | (38.7M) | (36.9M) | (36.9M) | (33.2M) | (31.6M) | |
Accounts Payable | 1.5M | 1.8M | 1.8M | 2.1M | 2.4M | 1.5M | |
Cash | 92.7K | 10.0M | 13.5M | 11.6M | 13.3M | 14.0M | |
Non Current Assets Total | 9.1M | 9.7M | 10.7M | 13.4M | 15.4M | 9.0M | |
Cash And Short Term Investments | 92.7K | 10.0M | 13.5M | 11.6M | 13.3M | 14.0M | |
Net Receivables | 1.9M | 4.2M | 3.1M | 4.2M | 4.8M | 5.0M | |
Common Stock Shares Outstanding | 104.8M | 141.7M | 141.7M | 137.9M | 158.6M | 166.5M | |
Liabilities And Stockholders Equity | 15.6M | 28.8M | 33.1M | 35.7M | 41.0M | 43.1M | |
Inventory | 4.3M | 4.4M | 5.3M | 5.8M | 6.6M | 6.9M | |
Other Current Assets | 220.1K | 495.0K | 546.3K | 767.5K | 882.6K | 926.7K | |
Other Stockholder Equity | 13.2M | 13.6M | 9.6M | 10.2M | 11.8M | 11.5M | |
Total Liab | 9.0M | 10.3M | 8.2M | 11.0M | 12.7M | 6.5M | |
Property Plant And Equipment Gross | 7.4M | 14.7M | 16.4M | 17.4M | 20.0M | 21.0M | |
Total Current Assets | 6.5M | 19.1M | 22.4M | 22.3M | 25.6M | 26.9M | |
Short Term Debt | 1.3M | 2.7M | 267.4K | 265.4K | 305.2K | 290.0K | |
Non Current Liabilities Total | 4.9M | 5.1M | 5.6M | 6.7M | 7.7M | 4.0M | |
Intangible Assets | 1.7M | 1.7M | 1.5M | 4.4M | 5.1M | 3.5M | |
Common Stock | 35.4M | 43.6M | 49.9M | 49.0M | 56.4M | 35.8M | |
Current Deferred Revenue | 1.3M | 742.9K | 554.6K | 2.0M | 2.3M | 2.4M | |
Net Tangible Assets | 5.6M | 4.9M | 16.9M | 23.4M | 27.0M | 28.3M | |
Long Term Debt | 4.5M | 4.1M | 4.7M | 5.7M | 5.1M | 3.8M | |
Short Long Term Debt | 2.6M | 1.1M | 2.4M | 111.1K | 100.0K | 95.0K | |
Property Plant Equipment | 6.7M | 7.4M | 8.1M | 8.9M | 8.0M | 7.4M | |
Long Term Debt Total | 4.3M | 4.9M | 5.1M | 5.6M | 6.4M | 5.5M | |
Capital Surpluse | 9.4M | 10.3M | 10.7M | 9.6M | 11.1M | 9.2M | |
Capital Lease Obligations | 541.9K | 1.2M | 1.0M | 854.0K | 982.1K | 589.3K | |
Net Invested Capital | 12.3M | 25.1M | 29.8M | 30.4M | 35.0M | 24.1M | |
Net Working Capital | 2.4M | 13.9M | 19.8M | 18.0M | 20.6M | 21.7M | |
Capital Stock | 35.4M | 43.6M | 49.9M | 49.0M | 56.4M | 45.1M |
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving against Microbix Stock
0.74 | RY-PM | Royal Bank | PairCorr |
0.68 | BNS | Bank of Nova Scotia | PairCorr |
0.67 | TD-PFI | Toronto Dominion Bank | PairCorr |
0.65 | RY-PS | Royal Bank | PairCorr |
0.58 | TD-PFD | Toronto Dominion Bank | PairCorr |
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
Balance Sheet is a snapshot of the financial position of Microbix Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Microbix Biosystems Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Microbix Biosystems and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Microbix currently owns. An asset can also be divided into two categories, current and non-current.